Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial
Authors
Keywords
-
Journal
PSYCHIATRY AND CLINICAL NEUROSCIENCES
Volume 70, Issue 11, Pages 517-526
Publisher
Wiley
Online
2016-08-04
DOI
10.1111/pcn.12430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients
- (2016) Hamid Emadi-Kouchak et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
- (2016) Ali Ghaleiha et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study
- (2016) Sahra Emamzadehfard et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- DNA damage and antioxidants in treatment naïve children with obsessive–compulsive disorder
- (2016) Şeref Şimşek et al. PSYCHIATRY RESEARCH
- Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
- (2015) Christopher Pittenger et al. JOURNAL OF CLINICAL PSYCHIATRY
- Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial
- (2015) M. Shalbafan et al. PHARMACOPSYCHIATRY
- Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder
- (2015) Demet Alici et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder
- (2014) Mahnaz Heidari et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study
- (2014) Mohammad-Reza Khodaie-Ardakani et al. PSYCHIATRY RESEARCH
- 12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive Disorder
- (2013) Paul J Grant et al. NEUROPSYCHOPHARMACOLOGY
- In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
- (2013) Mohammad Haghighi et al. PSYCHOPHARMACOLOGY
- Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder
- (2012) Neda Askari et al. CNS DRUGS
- Minocycline
- (2012) Olivia M. Dean et al. CNS DRUGS
- Obsessive–compulsive disorders
- (2012) Per Hove Thomsen EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study
- (2012) Ali Ghaleiha et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment
- (2011) Christopher Pittenger et al. PHARMACOLOGY & THERAPEUTICS
- The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder
- (2011) Ke Wu et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse
- (2011) Marianne Güldenpfennig et al. PHYSIOLOGY & BEHAVIOR
- Minocycline Augmentation of Pharmacotherapy in Obsessive-Compulsive Disorder
- (2010) Carolyn I. Rodriguez et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
- (2010) S. Evelyn Stewart et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice
- (2010) Felipe V. Gomes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clinical predictors of health-related quality of life in obsessive-compulsive disorder
- (2009) Umberto Albert et al. COMPREHENSIVE PSYCHIATRY
- Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
- (2009) Elias Aboujaoude et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Effects of agents targeting glutamatergic systems on marble-burying behavior
- (2009) Michihiko Iijima et al. NEUROSCIENCE LETTERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started